---
schema_version: "secwatch.filing_event.v1"
accession: "0000914475-23-000016"
form_type: "8-K"
ticker: "NBIX"
cik: "0000914475"
company_name: "NEUROCRINE BIOSCIENCES INC"
filed_at: "2023-02-24T23:59:59+00:00"
generated_at: "2026-06-19T01:13:16.790486+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Neurocrine closes collaboration with Voyager; pays $136M upfront, buys $39M in stock

## Summary
- Collaboration Agreement with Voyager became effective Feb 21, 2023 after HSR waiting period expired.
- Neurocrine paid Voyager ~$136M upfront and purchased 4,395,588 shares at $8.88/share for ~$39M.
- Jude Onyia, Neurocrine's CSO, appointed to Voyager's board per Amended Investor Agreement.

## SEC filing metadata
- accession: 0000914475-23-000016
- form_type: 8-K
- ticker: NBIX
- cik: 0000914475
- company_name: NEUROCRINE BIOSCIENCES INC
- filed_at: 2023-02-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914475/000091447523000016/0000914475-23-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914475/000091447523000016/nbix-20230221.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000914475-23-000016
- JSON: https://secwatch.observer/filing/0000914475-23-000016.json
- Plain text: https://secwatch.observer/filing/0000914475-23-000016.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.